Literature DB >> 7325887

Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice.

G F Mitchell, J M Curtis, E Handman.   

Abstract

When injected cutaneously with promastigotes of an isolate of Leishmania tropica, BALB/c mice develop progressive cutaneous disease whereas lesions in BALB/c.H-2k mice heal after several weeks. Lesions in BALB/c mice injected into deep subcutaneous tissues with promastigotes are less obvious early but much more prominent later than in mice after strict intradermal injection. BALB/c mice injected with Corynebacterium parvum together with a preparation of frozen and thawed infected macrophages are more resistant to cutaneous disease than mice injected with either adjuvant or crude antigen mixture alone. Results of these experiments, and those on other mouse strains reported previously, will aid in the choice of mouse and injection regime to be used in testing the efficacy of isolated L. tropica antigens as vaccines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325887     DOI: 10.1038/icb.1981.48

Source DB:  PubMed          Journal:  Aust J Exp Biol Med Sci        ISSN: 0004-945X


  8 in total

1.  Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis.

Authors:  S Mukhopadhyay; S Bhattacharyya; R Majhi; T De; K Naskar; S Majumdar; S Roy
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes.

Authors:  M Barral-Netto; S G Reed; M Sadigursky; G Sonnenfeld
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

3.  Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

Authors:  L Soong; S M Duboise; P Kima; D McMahon-Pratt
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

4.  Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis.

Authors:  J O Hill; R J North; F M Collins
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

5.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.

Authors:  P Scott; P Natovitz; R L Coffman; E Pearce; A Sher
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

6.  Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9.

Authors:  L J Roberts; T M Baldwin; J M Curtis; E Handman; S J Foote
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

Review 7.  Study of Leishmania pathogenesis in mice: experimental considerations.

Authors:  Corinne Loeuillet; Anne-Laure Bañuls; Mallorie Hide
Journal:  Parasit Vectors       Date:  2016-03-11       Impact factor: 3.876

8.  Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis.

Authors:  Y Belkaid; S Kamhawi; G Modi; J Valenzuela; N Noben-Trauth; E Rowton; J Ribeiro; D L Sacks
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.